10
775K
7
1
0.30
- Areas of investment
Summary
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the IESE BAN, startups are often financed by Economistes BAN, ESADE BAN. The meaningful sponsors for the fund in investment in the same round are ESADE BAN, Economistes BAN, Brainstorm Ventures. In the next rounds fund is usually obtained by Brainstorm Ventures, IESE Business School, Girbau.
The important activity for fund was in 2019. The real fund results show that this VC is 13 percentage points more often commits exit comparing to other companies. The common things for fund are deals in the range of 100 thousands - 1 million dollars. The fund is constantly included in less than 2 deals per year.
We can highlight the next thriving fund investment areas, such as Apps, Online Portals. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight MyPoppins.
Investments analytics
Analytics
- Total investments
- 10
- Lead investments
- 1
- Follow on index
- 0.30
- Investments by industry
- Information Services (3)
- Manufacturing (3)
- CleanTech (2)
- Online Portals (2)
- Software (2) Show 18 more
- Investments by region
-
- Spain (10)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 5
- Avg. valuation at time of investment
- 2M
- Group Appearance index
- 0.90
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| DIVE Medical | 13 Jan 2021 | Medical Device, Medical | Seed | 354K | Aragon, Zaragoza, Spain |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.